The distinguished TOP 100 Award.
We have received the award for Germany’s most innovative small and medium-sized enterprises.
The Löwenstein Group has won the TOP 100 innovation competition and now bears the TOP 100 seal 2025. Only particularly innovative medium-sized companies receive the award.
« Löwenstein combines a high capacity for innovation with the speed and flexibility of a medium-sized company, the long-term focus and market orientation of an owner-managed company and the opportunities of a medium-sized international group. This combination is unique in the industry worldwide. »
- Benjamin Löwenstein
CEO
The TOP 100 is based on a scientific selection process led by innovation researcher Prof. Dr. Nikolaus Franke. On behalf of compamedia, the organizer of the competition, he and his team analyzed the innovative capacity of the participating companies based on more than 100 evaluation criteria, which are divided into five categories:
- Innovation-promoting top management,
- Climate of innovation,
- Innovative processes and organization,
- External orientation/open innovation and
- Innovation success.
At its core, the TOP 100 analysis is about whether innovations are the result of structured innovation management in companies – or whether they arise by chance
We are working tirelessly to optimize our product range and develop even better solutions for our patients. Examples of this include the expansion of our diagnostic and monitoring options, the networking of clinical systems with cloud services and the use of algorithms and AI for therapy support. Our goal is to improve patient therapy and establish holistic integration between outpatient and inpatient treatment.
Benjamin Löwenstein
CEO